![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/56 | |
A61P 15/00 |
(11) | Number of the document | 3054957 |
(13) | Kind of document | T |
(96) | European patent application number | 14852485.3 |
Date of filing the European patent application | 2014-10-07 | |
(97) | Date of publication of the European application | 2016-08-17 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/059443 |
Date | 2014-10-07 |
(87) | Number | WO 2015/054213 |
Date | 2015-04-16 |
(30) | Number | Date | Country code |
201361887643 P | 2013-10-07 | US |
(72) |
WOTTON, Paul K., US
JAFFE, Jonathan, US
|
(73) |
Antares Pharma, Inc.,
100 Princeton South Corporate Center Suite 300, Ewing, NJ 08628,
US
|
(54) | HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |
HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |